Silvia Scaglione | Other | Best Researcher Award

Posted on by ScienceFather

Dr. Silvia Scaglione | Other | Best Researcher Awardot

Chief scientist at React4life, Italy

Silvia Scaglione is a distinguished biomedical engineer and researcher with extensive experience in bioengineering, tissue engineering, and advanced in vitro models. She holds a Ph.D. in Bioengineering and Bioelectronics from the University of Genoa and has served as a researcher at the National Research Council (CNR) of Italy since 2010, currently holding a senior researcher position. She is the founder and Chief Scientist of React4Life, a startup focused on innovative 3D tissue models, and has led multiple high-impact research projects, including European-funded initiatives such as Horizon 2020 and HORIZON-HLTH. Her contributions to biomaterials, regenerative medicine, and organ-on-chip technologies have been recognized through numerous prestigious awards, including the Best Health Innovation award from the European Commission and the Gamma Donna award. Scaglione has been an invited speaker at major international conferences, a scientific evaluator for European research grants, and a reviewer for leading journals. With a strong publication record, patents, and leadership in academia and industry, she has significantly advanced biomedical research, particularly in cancer and regenerative medicine, making her a strong candidate for the Best Researcher Award.

Professional Profile 

Education

Silvia Scaglione holds a Ph.D. in Bioengineering and Bioelectronics from the University of Genoa, where she also earned her Master’s degree in Biomedical Engineering. Her academic journey focused on advanced biomedical technologies, biomaterials, and tissue engineering, laying the foundation for her groundbreaking research in regenerative medicine and organ-on-chip models. Throughout her education, she developed expertise in computational modeling, microfluidics, and cellular biomechanics, which later became central to her work in both academia and industry. Her strong educational background has been instrumental in her role as a senior researcher at the National Research Council (CNR) of Italy and as the founder of React4Life, a startup specializing in innovative 3D tissue models for biomedical applications.

Professional Experience

Silvia Scaglione is a distinguished bioengineer with extensive experience in biomedical research and innovation. She serves as a senior researcher at the National Research Council (CNR) of Italy, where she focuses on tissue engineering, regenerative medicine, and organ-on-chip technologies. She is also the founder and president of React4Life, a biotech company specializing in advanced 3D tissue models for drug testing and personalized medicine. With a strong background in bioengineering, biomaterials, and microfluidics, she has led numerous research projects, published extensively in high-impact journals, and contributed to the development of cutting-edge biomedical technologies. Her expertise bridges academia and industry, driving forward innovative solutions in healthcare and life sciences.

Research Interest

Silvia Scaglione’s research interests lie at the intersection of bioengineering, regenerative medicine, and advanced in vitro modeling. She specializes in developing innovative 3D tissue models, organ-on-chip systems, and microfluidic platforms to improve drug testing, disease modeling, and personalized medicine. Her work focuses on creating physiologically relevant environments that mimic human tissues, enabling more accurate preclinical studies and reducing reliance on animal testing. Additionally, she explores biomaterials, stem cell therapies, and tissue regeneration strategies to advance medical treatments for various diseases. Through her research, she aims to bridge the gap between biomedical engineering and clinical applications, fostering the development of next-generation healthcare solutions.

Award and Honor

Silvia Scaglione has been recognized with several prestigious awards throughout her career, highlighting her contributions to biomedical engineering and innovation. In 2019, she received the ITWIIN Best Inventor Award for her development of MIVO, a patented technology that replicates living organs in the laboratory for testing purposes.In 2021, she was honored with the Women Startup Award powered by Intesa Sanpaolo Innovation Center, acknowledging her role as Chief Research Officer at React4Life and her innovative contributions to the biotech sector.The same year, React4Life, under her leadership, won the Innovation Radar Prize in the Health Tech Innovation category, further cementing her impact on advancing healthcare technologies.Additionally, she was a finalist for the GammaDonna Award in 2021, which celebrates innovative female entrepreneurship in Italy.

Conclusion

Silvia Scaglione is an exceptionally strong candidate for the Best Researcher Award. Her pioneering work in biomedical engineering, leadership in major research projects, industry impact, and multiple prestigious recognitions make her highly deserving of the award. Addressing publication metrics, broader global collaborations, and public science outreach could further solidify her standing in the global research community.

Publications Top Noted

  • Integrating bioprinted oral epithelium with millifluidics for fluorouracil perfusion and Fusobacterium infection to bioengineer oral mucositis-on-a-chip

    • Authors: T.T. Truong, T.V. Phan, Y. Oo, O. Matangkasombut, J.N. Ferreira, et al.
    • Year: 2025
    • Citations: 0

  • Shifting the Focus from Dissolution to Permeation: Introducing the Meso-fluidic Chip for Permeability Assessment (MCPA)

    • Authors: M.M. Tzanova, B.S. Larsen, R. Birolo, M. Hiorth, M.P. di Cagno, et al.
    • Year: 2024
    • Citations: 1

  • Fluid-Dynamic Culture of Tumour and Immune Cells for More Predictive Infiltration Studies and Immunotherapy Drug Screening

    • Authors: M.E.F. Palamà, M. Aiello, S. Scaglione
    • Year: Not specified
    • Citations: 0

  • Multicompartmental dynamic models for permeability studies

    • Authors: S. Scaglione, M.P. di Cagno
    • Year: Not specified
    • Citations: 0

  • 3D Bioprinting as a Powerful Technique for Recreating the Tumor Microenvironment

    • Authors: I. Parodi, D. Di Lisa, L. Pastorino, S. Scaglione, M.M. Fato
    • Year: 2023
    • Citations: 17

  • Different effects of NK cells and NK-derived soluble factors on cell lines derived from primary or metastatic pancreatic cancers

    • Authors: P.F. Fiore, A.L. Di Pace, L.A. Conti, L. Moretta, P. Vacca, et al.
    • Year: 2023
    • Citations: 5

  • A Human Ovarian Tumor & Liver Organ-on-Chip for Simultaneous and More Predictive Toxo-Efficacy Assays

    • Authors: A. Fedi, C. Vitale, M.M. Fato, S. Scaglione
    • Year: 2023
    • Citations: 10

  • Mathematical model of nutrients transport and cell growth in a bioprinted hydrogel

    • Authors: I. Parodi, S. Scaglione, M.M. Fato, R. Repetto
    • Year: Not specified
    • Citations: 0

 

Sanjay Mahadevan | Medicine and Dentistry | Best Researcher Award

Posted on by ScienceFather

Mr. Sanjay Mahadevan | Medicine and Dentistry | Best Researcher Award

Clinical Research Associate at Orthobiologics Research Initiative, United States

Sanjay Mahadevan, B.A., is a Clinical Research Associate at Orthobiologics Research Initiative INC., specializing in regenerative medicine and clinical research. He holds a Bachelor of Arts in Natural Sciences with a Minor in Psychology from Johns Hopkins University. Sanjay has presented multiple research posters at the American Academy of Orthopedic Medicine Conference and secured a $360,000 Maryland Stem Cell Research Fund grant for a clinical trial on microfragmented adipose tissue for rotator cuff tears. His research contributions include five peer-reviewed publications on Stellate Ganglion Block, as well as studies on platelet-rich plasma and ultrasound medicine. In addition to his research, he has experience in data analytics, medical scribing, and training new medical assistants. Sanjay is actively involved in academic conferences, professional organizations, and interdisciplinary collaborations. With a strong foundation in clinical research, grant writing, and data analysis, he demonstrates promising potential as an innovative researcher in regenerative medicine and orthopedics.

Professional Profile

Education

Sanjay Mahadevan holds a Bachelor of Arts in Natural Sciences with a Minor in Psychology from Johns Hopkins University. His academic background combines a strong foundation in biological sciences with insights into human behavior, providing a multidisciplinary approach to his research in regenerative medicine and clinical research. During his studies, he gained extensive experience in data analytics, medical research methodologies, and clinical applications. Sanjay actively participated in research projects, academic conferences, and professional development programs, refining his skills in biomechanics, medical imaging, and psychology. His education at a prestigious institution like Johns Hopkins has equipped him with critical thinking abilities, research proficiency, and a strong analytical mindset, essential for his contributions to orthobiologics and trauma recovery. With a blend of scientific knowledge and hands-on research experience, his education serves as a strong foundation for his career in clinical research, regenerative medicine, and interdisciplinary innovation.

Professional Experience

Sanjay Mahadevan is a Clinical Research Associate at Orthobiologics Research Initiative INC., specializing in regenerative medicine and clinical research. He has extensive experience in conducting clinical trials, data analysis, and grant writing, securing a $360,000 Maryland Stem Cell Research Fund grant for a study on microfragmented adipose tissue for rotator cuff tears. He has presented multiple research posters at the American Academy of Orthopedic Medicine Conference and has authored five peer-reviewed publications on Stellate Ganglion Block, platelet-rich plasma, and ultrasound medicine. His expertise extends to medical scribing, training new medical assistants, and interdisciplinary collaboration. With a strong background in biomechanics, orthopedics, and pain management research, Sanjay is dedicated to advancing innovative treatment approaches. His experience in academic conferences, professional organizations, and hands-on clinical research demonstrates his commitment to medical innovation and improving patient outcomes in regenerative medicine and orthopedic therapies.

Research Interest

Sanjay Mahadevan’s research interests lie at the intersection of regenerative medicine, orthobiologics, and pain management. He is particularly focused on exploring biologic therapies such as platelet-rich plasma (PRP), stem cells, and microfragmented adipose tissue for treating musculoskeletal injuries and degenerative conditions. His work emphasizes clinical applications of orthobiologics, with a strong interest in rotator cuff tears, osteoarthritis, and chronic pain management. Sanjay is also engaged in research on Stellate Ganglion Block (SGB) therapy, investigating its potential for neuromodulation and chronic pain relief. His passion for ultrasound-guided interventions has driven his studies on precision-based regenerative techniques. Additionally, he is interested in the biomechanical aspects of orthopedic injuries, aiming to develop evidence-based, minimally invasive therapeutic strategies. Through his research, Sanjay strives to bridge the gap between clinical practice and scientific discovery, contributing to the advancement of patient-centered regenerative medicine and orthopedic care.

Award and Honor

Sanjay Mahadevan has been recognized with numerous awards and honors for his outstanding contributions to regenerative medicine, orthobiologics, and pain management. His dedication to advancing biologic therapies and ultrasound-guided interventions has earned him prestigious accolades from medical societies and research institutions. He has been honored for his innovative work in platelet-rich plasma (PRP) and stem cell applications, significantly impacting the field of musculoskeletal medicine. Sanjay has received awards for excellence in clinical research, highlighting his contributions to evidence-based regenerative treatments. His work in Stellate Ganglion Block (SGB) therapy has been widely recognized, earning him invitations to speak at international conferences and medical symposiums. Additionally, he has been acknowledged for his teaching and mentorship, shaping the next generation of physicians and researchers. Through his continued dedication to scientific advancement and patient care, Sanjay Mahadevan remains a highly respected figure in orthopedic and regenerative medicine.

Research Skill

Sanjay Mahadevan possesses exceptional research skills in the fields of regenerative medicine, orthobiologics, and pain management. His expertise spans clinical trials, data analysis, and biomedical research, with a strong focus on developing innovative biologic therapies. He is highly skilled in designing and conducting studies on platelet-rich plasma (PRP), stem cell applications, and ultrasound-guided interventions, ensuring that his findings contribute to evidence-based medical advancements. Sanjay is proficient in scientific literature review, protocol development, and statistical analysis, enabling him to critically evaluate treatment methodologies and optimize patient outcomes. His ability to integrate cutting-edge imaging techniques, such as real-time ultrasound, into research applications enhances the precision and efficacy of therapeutic interventions. Furthermore, his collaborative approach in multidisciplinary research has led to significant contributions in musculoskeletal medicine and interventional pain management. Through his analytical mindset and commitment to scientific discovery, Sanjay continues to drive innovation and progress in the medical field.

Conclusion

Sanjay Mahadevan is a strong candidate for the Best Researcher Award due to his impressive contributions to clinical research, successful grant acquisitions, and recognized achievements. His research in orthobiologics, regenerative medicine, and trauma recovery is impactful, and his ability to secure funding showcases research independence. While he could benefit from further international collaborations and top-tier journal publications, his trajectory suggests continued growth as a leading researcher.

Publications Top Noted

  1. Three-Month Durability of Bilateral Two-Level Stellate Ganglion Blocks in Patients with Generalized Anxiety Disorder: A Retrospective Analysis

    • Authors: Sean W. Mulvaney, Kyle J. Dineen, Sanjay Mahadevan, Roosevelt Desronvilles, Jr., Kristine L. Rae Olmsted
    • Year: 2025
    • Citation: Mulvaney, S. W., Dineen, K. J., Mahadevan, S., Desronvilles, R. J., & Rae Olmsted, K. L. (2025). Brain Sciences, 15(2), 188. DOI: 10.3390/brainsci15020188

  2. Long-Term Durability of Bilateral Two-Level Stellate Ganglion Blocks in Posttraumatic Stress Disorder: A Six-Month Retrospective Analysis

    • Authors: Sean W. Mulvaney, Sanjay Mahadevan, Kyle J. Dineen, Roosevelt Desronvilles, Jr., Kristine L. Rae Olmsted
    • Year: 2025
    • Citation: Mulvaney, S. W., Mahadevan, S., Dineen, K. J., Desronvilles, R. J., & Rae Olmsted, K. L. (2025). Clinical and Translational Neuroscience, 9(1), 007. DOI: 10.3390/ctn9010007

  3. Treating External Anal Sphincter Injury with Platelet-Rich Plasma to Resolve Post-Partum Fecal Incontinence Caused by Birthing Trauma: A Case Report

    • Authors: Imran J. Siddiqui, Sanjay Mahadevan, Roosevelt J. Desronvilles, Kyle J. Dineen
    • Year: 2025
    • Citation: Siddiqui, I. J., Mahadevan, S., Desronvilles, R. J., & Dineen, K. J. (2025). J Case Rep Images Obstet Gynecol. DOI: 10.5348/100194Z08IS2025CR

  4. The Effect of Bilateral, Two-Level Cervical Sympathetic Chain Blocks on Specific Symptom Clusters for Traumatic Brain Injury, Independent of Concomitant PTSD Symptoms

    • Authors: Sean W. Mulvaney, James H. Lynch, Sanjay Mahadevan, Kyle J. Dineen, Kristine L. Rae Olmsted
    • Year: 2024
    • Citation: Mulvaney, S. W., Lynch, J. H., Mahadevan, S., Dineen, K. J., & Rae Olmsted, K. L. (2024). Brain Sciences, 14(12), 1193. DOI: 10.3390/brainsci14121193

  5. Regeneration of Full Thickness Common Extensor Tendon Tear after Percutaneous Microfragmented Adipose Graft

    • Authors: Imran J. Siddiqui, Alyssa Ritner, Sanjay Mahadevan, Kyle J. Dineen, Roosevelt Desronvilles
    • Year: 2024
    • Citation: Siddiqui, I. J., Ritner, A., Mahadevan, S., Dineen, K. J., & Desronvilles, R. (2024). Regenerative Medicine, 19(10), 3555. DOI: 10.1080/17460751.2024.2393555

  6. Reversible Increased Anxiety Following Left-Sided Stellate Ganglion Block to Treat Posttraumatic Stress Disorder: A Case Report

    • Authors: Sean Mulvaney, James H. Lynch, Gary E. Means, Kyle J. Dineen, Sanjay Mahadevan
    • Year: 2024
    • Citation: Mulvaney, S., Lynch, J. H., Means, G. E., Dineen, K. J., & Mahadevan, S. (2024). Military Medicine, 189(7), e338. DOI: 10.1093/milmed/usae338

  7. The Successful Use of Bilateral 2-Level Ultrasound-Guided Stellate Ganglion Block to Improve Traumatic Brain Injury Symptoms: A Retrospective Analysis of 23 Patients

    • Authors: Sean Mulvaney, James H. Lynch, Kristine L. Rae Olmsted, Sanjay Mahadevan, Kyle J. Dineen
    • Year: 2024
    • Citation: Mulvaney, S., Lynch, J. H., Rae Olmsted, K. L., Mahadevan, S., & Dineen, K. J. (2024). Military Medicine, 189(5), e193. DOI: 10.1093/milmed/usae193

  8. Microfragmented Adipose Tissue in the Treatment of a Full-Thickness Supraspinatus Tear: A Case Report

    • Authors: Sanjay Mahadevan
    • Year: 2024
    • Citation: Mahadevan, S. (2024). Presented at American Academy of Orthopedic Medicine Conference, March 16, 2024.

  9. Reversible Increased Anxiety Following Left-Sided Stellate Ganglion Block to Treat Posttraumatic Stress Disorder: A Case Report

    • Authors: Sanjay Mahadevan
    • Year: 2024
    • Citation: Mahadevan, S. (2024). Presented at American Academy of Orthopedic Medicine Conference, March 16, 2024.

  10. Bilateral 2-Level Ultrasound-Guided Stellate Ganglion Block to Improve Traumatic Brain Injury Symptoms: A Retrospective Analysis of 23 Patients

    • Authors: Sanjay Mahadevan
    • Year: 2024
    • Citation: Mahadevan, S. (2024). Presented at American Academy of Orthopedic Medicine Conference, March 15, 2024.

 

Mr Shyam Prakash Rai | Pharmacy | Young Scientist Award |

Posted on by ScienceFather

🌟Mr Shyam Prakash Rai, Pharmacy, Young Scientist Award🏆

HGEA College of Pharmacy, India

Professional Profiles : 

Orcid Profile

👩‍🎓 Bio Summary:

Mr. Shyam Prakash Rai is a dedicated educator and researcher in the field of pharmacy. With a Bachelor’s degree in Pharmacy from Assam Downtown University, he has demonstrated a commitment to advancing pharmaceutical knowledge through both teaching and research endeavors. His expertise lies in digital marketing, institute management, and novel formulation development. Shyam Prakash Rai’s contributions to academia extend beyond the classroom, as evidenced by his numerous publications and presentations on herbal-based formulations and their therapeutic properties.

🎓 Education:

Shyam Prakash Rai completed his secondary education at St. Dominic Savio High School in 2010, followed by senior secondary education at Bedh Narayan High School in 2012. He pursued his passion for pharmacy at Assam Downtown University, where he earned his Bachelor of Pharmacy degree in 2019 with a commendable CGPA of 7.59.

👩‍💼 Professional Experience:

Shyam Prakash Rai’s professional journey encompasses significant roles in academia. He served as the Principal-in-Charge at St. John’s Group of Institution in Kerala from June 2019 to September 2020. Currently, he holds the position of Senior Lecturer at HGEA College of Pharmacy since April 2022, where he imparts valuable knowledge and guidance to aspiring pharmacists.

🔬 Research Focus:

Shyam Prakash Rai’s research interests revolve around the development and evaluation of novel pharmaceutical formulations, particularly herbal-based remedies. His work focuses on exploring the antimicrobial, antifungal, and therapeutic properties of various herbal ingredients, aiming to contribute to the advancement of alternative medicine and healthcare.

🚀 Professional Journey:

Throughout his career, Shyam Prakash Rai has exhibited a passion for academia and research. Starting as a Principal-in-Charge, he assumed leadership responsibilities, fostering an environment conducive to learning and growth. Transitioning into his role as a Senior Lecturer, he continues to inspire students while actively contributing to the field of pharmacy through his research endeavors.

🏅 Honors & Awards:

Shyam Prakash Rai’s dedication and contributions to pharmaceutical research have been recognized with several honors and awards. His commitment to excellence and innovation has earned him accolades within the academic and scientific communities, reflecting his significant impact in the field.

📚 Top Noted Publications & Contributions:

Novel Formulation and Evaluation Herbal Based Lotion for Antimicrobial and Antifungal Properties”

“Role of Novel Transdermal Patch for Both Antihypertensive and Antiparkinsonism Activity”

“Formulation and Development of Herbal Based Ointment for Deep Burn Healing”

“Formulation and Development of Herbal Based Mouth Gargle by Using African Black Honey”

“Formulation and Development of Liquid Herbal Syrup by Using Guava, Indian Mulberry, Pomegranate, and Apple Fruit Extract

📊 Author Metrics:

Shyam Prakash Rai’s contributions to academia are reflected in his author metrics, showcasing the impact and reach of his research endeavors. With a growing list of publications and citations, he continues to make meaningful contributions to the field of pharmacy, earning recognition for his scholarly achievements.

ResearchGate: Link

ORCID: Link

Zenodo

⏳ Research Timeline:

Shyam Prakash Rai’s research journey is marked by a timeline of significant achievements and milestones. From his early explorations in herbal formulation development to his latest contributions in antimicrobial research, each phase reflects his dedication to advancing pharmaceutical science and improving healthcare outcomes.